$JNJ: Heartline Rejection Targeting 38.2%-61.8% Retrace

20 בינו׳ 2023

Johnson & Johnson has rejected the Heartline of the Equidistant Channel while showing Bearish Divergence on the MACD and RSI and as a result i now think it will be heading for a minimum .382-.618 Retrace and i will be playing it via monthly put options.